|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Affibody AB, of Stockholm, Sweden, entered a research agreement with GE Healthcare, a division of the General Electric Co., of Fairfield, Conn. Under the agreement, Affibody will provide molecules for three disease targets as defined by GE Healthcare to allow early diagnosis of disease to optimize therapy on a personalized basis. Under the agreement, GE Healthcare has the exclusive option to take any licenses required for developing and commercializing imaging agents resulting from the collaboration.
o Amorcyte Inc., of Hackensack, N.J., concluded its first round of financing, bringing in $4.2 million to fund its initial Phase I trial of a cell therapy product ...